Research & Development: Page 69

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Video Detailing: 10 Years in the Making

    With the proliferation of broadband and advances in technology, e-promotional and educational online activities are on the rise. Detail videos may not have revolutionized the pharma industry in quite the way MTV has revolutionized the music industry, but the medium is gaining traction 10 years af...

    By Robin Robinson • Jan. 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    We are honored to receive this prestigious Enterprise award from Eastern Technology Council, says Robert Broeze, Ph.D., President and CEO of Laureate Pharma. Dr. Broeze, who is with Dr. Michiel Ultee, VP of Process Sciences, in front of an Applikon 20L Bioreactor, says the award validates the com...

    By PharmaVoice Team • Jan. 28, 2009
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL William GARBARINI Jr. Ferring Promotes Head of Orthopedics and Urology Business Ferring Pharmaceuticals has promoted William Garbarini Jr. to VP of its orthopedics and urology business unit, recently formed by the merging of these clinical product areas. Mr. Garbarini was formerly exe...

    By PharmaVoice Team • Jan. 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Lathian Health Offers Closed-Loop Promotion Tool Informa Launches CRM/ROI Tracking Solution Verticals onDemand Offers Analytics and Reporting Solution OpenQ Unveils KOL Solutions Tibco Spotfire Solution Speeds Dru...

    By PharmaVoice Team • Jan. 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    FemmePharma Global Healthcare Inc. is devoted to developing drugs for diseases and disorders disproportionately affecting women. For more information, visit femmepharma.com. The International Society for Medical Publication Professionals (ISMPP) is a not-for-profit organization for medical public...

    By PharmaVoice Team • Jan. 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, marketing, And R&D Trends affecting the healthcare industry U.S. Biochip Market to Reach $2.5 Billion in 2012 U.S. demand for biochip products and services is forecast to grow 9.9% annually, to $2.5 billion in 2012, led by uses in drug discovery and epidemiological research. According ...

    By PharmaVoice Team • Jan. 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    When it comes to making drugs safer, cheaper, and more effective, few fields have shown more promise than molecular diagnostics. But the full potential of this revolutionary area of medical research has yet to be reached, not because of technological barriers — although they do exist — but becaus...

    By Peter Pitts • Jan. 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    UpFront Milestones Almac turns 20 Dr. Robert Dunlop, president and managing director of Almac Clinical Services (left), and Sir Allen McClay, chairman of Almac Group, celebrate the division’s 20th anniversary. Almac Clinical Services, one of the key divisions at Almac Group, has grown to become t...

    By PharmaVoice Team • Jan. 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    ON THE COVER Partnering for Success In these times of adversity, strategic alliances become even more crucial than ever for survival. FEATURES No Pens or Mugs? No Problem. The industry is discovering it won’t lose the ability to message effectively under the new PhRMA code. The Green o...

    By PharmaVoice Team • Dec. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Benefits of Prelaunch Access

    Contributed by Natalie Douglas, CEO, IDIS Prelaunch access to drugs can provide months and perhaps years of treatment for patients with unmet medical needs when all other therapeutic options have failed or no other options are available. The benefits of named- patient programs are best realized w...

    By Natalie Douglas • Dec. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Sirtris’ Dr. Michelle Dipp discusses maintaining corporate culture while integrating cutting-edge science and technology. Biotech business leader Michelle Dipp, M.D., Ph.D., has transitioned from a scientific background — with a medical degree and a Ph.D. — to the corporate side of the life-scien...

    By PharmaVoice Team • Dec. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Alex Gorsky Sheri McCoy Johnson & Johnson Shifts Executives Global healthcare company Johnson & Johnson has appointed Alex Gorsky worldwide chairman, surgical care group, with responsibility for the surgical franchises Ethicon, Ethicon Endo-Surgery, and DePuy, as well ...

    By PharmaVoice Team • Dec. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Cost Deters Cancer Patients from Seeking Treatment In addition to considerable physical and emotional burdens, cancer patients must also shoulder costly treatments resulting from their disease. A recent Thomson Reuters survey shows that the financial repercussions of cancer are taking a toll on p...

    By PharmaVoice Team • Dec. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Doctors' Choice Awards

    Identifying POWERful MEDICAL ADVERTISING 6th Annual Program Generated Responses From More Than 5,700 Physicians Dusa’s ClindaReach and Pfizer’s Chantix Highest Scoring Ads ClindaReach Category: Highest-Scoring Ad (Specialist Audience) Marketer: Dusa Agency: Topin & Associates Chantix Category...

    By PharmaVoice Team • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Patient Recruitment

    RESEARCH & Development BY DENISE MYSHKO Patient Recruitment The Continuing Saga of Patient-Recruitment Bottlenecks If patient recruitment wasn’t already hard enough, larger, more complex trials have made the enrollment of patients even more challenging. Clinical-trial patient recruitment and ...

    By Denise Myshko • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Personalized Medicine

    RESEARCH & Development PERSONALIZED MEDICINE The Right Dose at the Right time BY DENISE MYSHKO Obstacles and challenges still remain to make the vision of personalized medicine a reality. Despite some early successes, the development of targeted medicines and pharmacogenomics-based testing ha...

    By Denise Myshko • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Early Research

    RESEARCH & Development Early Research The Future of innovation Discovery and research technologies are advancing and will have a tremendous impact on the pipelines of the future. BY DENISE MYSHKO The way new medicines are discovered is on the cusp of revolutionary change. Advances in the unde...

    By Denise Myshko • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    At A Glance

    Looking Forward At a GLANCE This special Year in Preview issue provides insights into the trends that will impact the industry in the coming year and beyond. Below are some highlights from the sectors covered in the following pages. Focus on specialty markets David Avitabile President JFK Communi...

    By PharmaVoice Team • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Dr. Barry Goldstein Merck Appoints Head of Diabetes, Obesity Development Global pharmaceutical company Merck, Whitehouse Station, N.J., has named Barry Goldstein, M.D., Ph.D., FACP, FACE, VP of diabetes and obesity clinical development. In addition to leading overall development of co...

    By PharmaVoice Team • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    CONSUMER PERSPECTIVE Consumers Wary of Therapeutic Switches Almost three quarters of prescription drug users would be very concerned if a drug they were prescribed was switched to another drug designed to treat the same condition without their doctor’s knowledge, according to a survey released by...

    By PharmaVoice Team • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    eClinical Meets eLearning - Integrated eLearning Enables Efficient

    16 October 2008 VIEW on ESolutions ECLINICAL Multifunction eClinical systems are becoming the norm for capturing and managing data in clinical trials. Unfortunately, the training of site staff to use these systems is still taking place in one on one sessions or at investigator meetings. The use o...

    By PharmaVoice Team • Oct. 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Where eClinical Meets Business Process

    14 October 2008 VIEW on ESolutions ECLINICAL Early electronic data capture focused on finding efficiencies in data management activities, such as data entry and cleaning. When eClinical hit the mainstream, it delivered a clear view of complete trial data on a realtime basis, enabling clinical tri...

    By PharmaVoice Team • Oct. 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    4 October 2008 VIEW on ESolutions TABLE OF CONTENTS Letter from the Editor The Forum Hitting a MobileTarget: New technologies, such as social networking and wireless mobile applications, have the potential to connect pharma with consumers, patients, and physicians more quickly and effectively tha...

    By PharmaVoice Team • Oct. 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Joe Jimenez: Straightforward and Consumer Focused

    BY KIM RIBBINK COMPLETE The Package With an ability to step back from the protracted machinations that often prevail at pharma companies, is leading Novartis with a focus on the customer and a commitment to meeting goals and priorities. JOE Jimenez Sometimes it’s the simplest observations that he...

    By Kim Ribbink • Sept. 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Life After the Focus Group

    BY ROBIN ROBINSON IS THE FOCUS GROUP DEAD OR JUST DECLINING? While some people say the focus group is dead, others say it will never entirely disappear. Their opinions hinge on what position they hold in the market research process and what objective the research is trying to meet (turn to page 3...

    By Robin Robinson • Sept. 30, 2008